Table 1.
Patients’ characteristics and clinical features at presentation.
| Features | |
|---|---|
| Age (yrs); mean (SD) | 11.6 ± 4 |
| Gender; n (%) | |
| Female | 2 (17) |
| Male | 10 (83) |
| Duration of the disease before vitrectomy (months); median (range) | 5 (2–24) |
| Treatments received before surgical intervention | |
| Systemic steroids (Prednisolone 1 mg/kg/day) | 12 (100) |
| Antiparasitic drugs | 1 (6.7) |
| Peribulbar steroids (Subtenon Triamcinolone Acetonide 4 mg/ml) | 8 (53.3) |
| Topical steroids (Prednisolone acetate 1% eyedrops) and cycloplegics | 12 (100) |
| CDVA; median (range) | 20/630 (20/20000–20/125) |
| IOP (mmHg); mean (SD) | 11.3 ± 3 |
| Anterior chamber cells grading median (range) | 2 (1–3) |
| Posterior synechiae, n (%) | 13 (86.6) |
| Lens status, n (%) | |
| Clear | 1 (6.67) |
| Localized cataract | 7 (46.7) |
| Total lens opacity | 7 (46.7) |
| Vitritis grading, n (%) | |
| 0 | 0 |
| I | 0 |
| II | 0 |
| III | 4 (26.7) |
| IV | 4 (26.7) |
| Cannot be assessed clinically | 7 (46.6) |
CDVA corrected distance visual acuity, IOP intraocular pressure.